Table 2.
Cox model analysis for the correlation between RIG-I expression and patients’ clinical parameters
| Clinical parameters | Uni-variate | Multi-variate | ||
|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | |
| Gender (M/F) | 0.924 (0.528–1.616) | 0.781 | 0.733 (0.399–1.350) | 0.319 |
| Age (years) (≥ 60/< 60) | 1.391 (0.736–2.536) | 0.281 | 1.916 (1.010–3.636) | 0.047 |
| Tumor size (≥ 5 cm/< 5 cm) | 1.726 (0.999–2.984) | 0.051 | 1.077 (0.575–2.017) | 0.816 |
| Pathological stage (III + IV/I + II) | 1.961 (0.883–4.355) | 0.098 | 0.860 (0.358–2.067) | 0.860 |
| Tumor stage (T3 + T4/T1 + T2) | 2.564 (0.923–7.127) | 0.071 | 1.705 (0.588–4.941) | 0.326 |
| Lymph node metastasis (yes/no) | 2.494 (1.170–5.314) | 0.018 | 1.837 (0.621–5.437) | 0.272 |
| Distant metastasis (yes/no) | 2.547 (1.187–5.466) | 0.016 | 2.117 (0.907–4.940) | 0.083 |
| TNM stage (III + IV/I + II) | 3.017 (1.620–5.617) | 0.000 | 2.503 (1.047–5.980) | 0.039 |
| RIG-I expression (High/low) | 0.400 (0.226–0.708) | 0.023 | 0.404 (0.210–0.777) | 0.007 |